Article Name Medtech
Investment to expand the R&D centre and scale up to 1500+ employees in 5 years
18th May, 2023
Dr Mansukh Mandaviya interacts with representatives of Japanese Medical Devices Companies
16th May, 2023
Contributing to the growth of the healthcare sector in the region
11th May, 2023
Valvular heart disease is a common health problem in India, particularly among older adults
08th May, 2023
MedTech industry leaders and diplomats from various embassies exchange ideas to explore new business avenues
06th May, 2023
Training partnership aims to expand access to robotic-assisted surgery in India
03rd May, 2023
To focus on accelerating growth and improving business fundamentals
02nd May, 2023
Specialising in medical-grade IoT sensors and remote monitoring services
26th April, 2023
The response of the fabricated device was investigated with real samples
25th April, 2023
Department and Industry Associations to organise 3 days National Level Expo in Gandhi Nagar, Gujarat
24th April, 2023
In the day-long event, MTaI will hold various discussions with Diplomats and Industry Stakeholders for investment possibilities in the Indian medtech space
20th April, 2023
Collaborates with Tricog to enable remote patient management
18th April, 2023
Manipal Hospitals and Queen Elizabeth University Hospital – Interventional Radiology departments ink partnership
17th April, 2023
The government has taken several cautious steps to fuel this promising sector. Strategic decisions such as foreign direct investments (FDI) promoting medical device parks are aimed to drive business. Let us look at how the industry has come along with this ‘Make in India’ initiative.
09th April, 2023
Koning Corporation, a global leader in breast computed tomography (CT) technology, is thrilled to announce the launch of its breakthrough Artificial Intelligence (AI) software, designed to enhance image quality significantly. The upgrade to their software system is set to provide unparalleled clarity in breast imaging, promising a game-changing impact on the early detection and treatment of breast cancer.
28th June, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease.
28th June, 2023
Next-generation FDA-cleared medical device brings non-invasive heart and lung disease detection to healthcare professionals at the point of care
28th June, 2023
SYBLEU INC. (OTC PINK: SYBE), a biotechnology company focused on therapies for human and animal health, medical devices, and clinical diagnostics, is preparing to begin advancing small molecule drug therapies for animal and human health.
28th June, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer